Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein

被引:36
|
作者
Marbeuf-Gueye, C
Ettori, D
Priebe, W
Kozlowski, H
Garnier-Suillerot, A
机构
[1] Univ Paris 13, UPRES A7033, Lab Physicochim Biomol & Cellulaire, F-93017 Bobigny, France
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Wroclaw B Beirut Univ, Inst Chem, PL-50383 Wroclaw, Poland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1999年 / 1450卷 / 03期
关键词
multidrug resistance; P-glycoprotein; MRP; doxorubicin; kinetic; resistance factor;
D O I
10.1016/S0167-4889(99)00060-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multidrug resistance (MDR) in model systems is known to be conferred by two different integral proteins, the 170-kDa P-glycoprotein (Pgp) and the 190-kDa multidrug resistance associated protein (MRP1). One possible pharmacological approach to overcome drug resistance is the use of specific inhibitors, which enhance the cytotoxicity of known antineoplastic agents. However, while many compounds have been proven to be very efficient in inhibiting Pgp activity only some of them are able to inhibit MRP1. The other Likely approach is based on the design and synthesis of new non-cross-resistant drugs with physicochemical properties favoring the uptake of the drug by the resistant cells. The intracellular drug retention influences its cytotoxic effect. The level of the intracellular drug content is a function of the amount of drug transported inside the cell (influx) and the amount of drug expelled from the cell (efflux). In this work, the kinetics of drug uptake and the kinetics of active efflux of several anthracycline derivatives in both Pgp expressing K562/Adr cells and MRP1 expressing GLC4/Adr cells was determined. Our data have shown that in both cell lines there is no correlation between the resistance Factor and the kinetics of drug efflux by these pumping systems. However, a very good correlation between the resistance factor and the kinetics of drug uptake has been established in both cell lines: the resistance factor decreases when the kinetics of drug uptake increases; This work has clearly shown that when the rate of transmembrane transport of anthracycline is high enough, the efflux mediated by the protein transporter is not able to pace with it. The protein transporter essentially operates in a futile cycle and the resistance factor is tending to one. It does not mean, however, that when the resistance factor is close to one the anthracycline is not transported by the pump. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:374 / 384
页数:11
相关论文
共 50 条
  • [21] Redefine the role of D-α-Tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein, multidrug resistance protein 1, and breast cancer resistance protein mediated cancer multidrug resistance
    Chen, Jing-Yi
    Sung, Chieh-Ju
    Chen, Ssu-Chi
    Hsiang, Yi-Ping
    Hsu, Yung-Chia
    Teng, Yu-Ning
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 190
  • [22] Taxifolin Resensitizes Multidrug Resistance Cancer Cells via Uncompetitive Inhibition of P-Glycoprotein Function
    Chen, Hsiu-Ju
    Chung, Yun-Lung
    Li, Chia-Ying
    Chang, Ying-Tzu
    Wang, Charles C. N.
    Lee, Hsiang-Yen
    Lin, Hui-Yi
    Hung, Chin-Chuan
    MOLECULES, 2018, 23 (12):
  • [23] EFFECTS OF PHOSPHORYLATION OF P-GLYCOPROTEIN ON MULTIDRUG-RESISTANCE
    GERMANN, UA
    CHAMBERS, TC
    AMBUDKAR, SV
    PASTAN, I
    GOTTESMAN, MM
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1995, 27 (01) : 53 - 61
  • [24] Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells
    Qian, F
    Wei, DZ
    Zhang, Q
    Yang, SL
    BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (03) : 64 - 69
  • [25] Effect of multidrug resistance 1/P-glycoprotein on the hypoxia-induced multidrug resistance of human laryngeal cancer cells
    Li, Dawei
    Zhou, Liang
    Huang, Jiameng
    Xiao, Xiyan
    ONCOLOGY LETTERS, 2016, 12 (02) : 1569 - 1574
  • [26] INTERACTION OF TAMOXIFEN WITH THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN
    CALLAGHAN, R
    HIGGINS, CF
    BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 294 - 299
  • [27] Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells
    Hu, YP
    Haq, B
    Carraway, KL
    Savaraj, N
    Lampidis, TJ
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (09) : 1419 - 1425
  • [28] Multidrug resistance, in small cell lung cancer: Expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease
    Triller, Nadja
    Korosec, Peter
    Kern, Izidor
    Kosnik, Mitja
    Debeljak, Andrej
    LUNG CANCER, 2006, 54 (02) : 235 - 240
  • [29] High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide
    Guertin, Amy D.
    O'Neil, Jennifer
    Stoeck, Alexander
    Reddy, Joseph A.
    Cristescu, Razvan
    Haines, Brian B.
    Hinton, Marlene C.
    Dorton, Ryan
    Bloomfield, Alicia
    Nelson, Melissa
    Vetzel, Marilynn
    Lejnine, Serguei
    Nebozhyn, Michael
    Zhang, Theresa
    Loboda, Andrey
    Picard, Kristen L.
    Schmidt, Emmett V.
    Dussault, Isabelle
    Leamon, Christopher P.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (08) : 1998 - 2008
  • [30] Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells
    Kurowski, C
    Berthold, F
    ANNALS OF ONCOLOGY, 1998, 9 (09) : 1009 - 1014